Preliminary Guidelines for the Use of IVIg during COVID-19

Journals Menu

Follow SCIRP

ISSN Print: 2162-2000
ISSN Online: 2162-2019
www.scirp.org/journal/wjns
E-mail: wjns@scirp.org

Citations h5-index & Ranking

"Preliminary Guidelines for the Use of IVIg during COVID-19"
written by David S. Younger,
published by World Journal of Neuroscience, Vol.11 No.2, 2021

has been cited by the following article(s):

[1]	Immune-based therapeutic approaches in COVID-19
	Biomedicine & …, 2022

[2]	18 CHAPTER Inflammatory Myopathies
	Motor Disorders, 2014

[1]	In-hospital care of children with COVID‐19 Pediatrics & Neonatology, 2024 DOI:10.1016/j.pedneo.2023.02.009

[2]	Immune-based therapeutic approaches in COVID-19 Biomedicine & Pharmacotherapy, 2022 DOI:10.1016/j.biopha.2022.113107

[3]	Immune-based therapeutic approaches in COVID-19 Biomedicine & Pharmacotherapy, 2022 DOI:10.1016/j.biopha.2022.113107

[4]	Immune-based therapeutic approaches in COVID-19 Biomedicine & Pharmacotherapy, 2022 DOI:10.1016/j.biopha.2022.113107

Follow SCIRP